Gastric Neoplasms: Clinical Trials

7 trials for Gastric Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 not yet recruiting, 1 unknown, 1 withdrawn. 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 27Completed 3, Not yet recruiting 2, Unknown 1, Withdrawn 1

Follow Gastric Neoplasms: new trials by email Literature Review of Gastric Neoplasms trials Research Report on Gastric Neoplasms

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exploring the Efficacy of Ferrous Sulfate/Ferrous Succinate Combined With Serplulimab and SOX Regimen in Neoadjuvant Therapy for Gastric Cancer: A Prospective Cohort Study
Ferrous succinate, Ferrous Sulfate, Serplulimab - Gastric Neoplasms
Phase 2Not yet recruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology542026-09-012026-10-14
Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor
Trastuzumab Rezetecan - Solid Tumors, Neoplasms (Cancer / Tumors)
Phase 2Not yet recruitingHaihua Yuan152026-06-152026-06-08
Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers
Cellvizio (Registered trademark) Real-Time In Vivo Cellular Imaging Platform with Confocal Miniprobes, Olympus Graphics Interchange Format (GIF) 190 endoscope, Gastric mucosal biopsy - Gastric Cancer, Gastric Neoplasms
Phase 2CompletedNational Cancer Institute (NCI)1952023-06-222025-01-17
Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Camrelizumab, Pyrotinib, Capecitabine - Gastric Neoplasms, Gastroesophageal Junction Adenocarcinoma
Phase 2UnknownFudan University652021-12-312021-11-08
Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer
intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) - Gastric Neoplasms
Phase 2WithdrawnUniversity Hospital Tuebingen2019-11-012025-04-03
Confocal Endoscopic Microscopy for Detection of Early Stage Gastric Cancer in Subjects With Hereditary Diffuse Gastric Cancer Syndrome
Endoscope+Cellvizio(R) 100 microscope - Gastric Cancer, Gastric Neoplasms
Phase 2CompletedNational Cancer Institute (NCI)372019-02-112021-07-12
A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2
ASLAN001 - Stomach Neoplasms, Cancer of Stomach
Phase 2CompletedASLAN Pharmaceuticals242012-03-012015-01-14

Narrower conditions

Stomach Neoplasms (7)  ·  Disease (2)  ·  Biliary Tract Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Transitional Cell (1)  ·  Colorectal Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Broader conditions

Digestive System Diseases (7)  ·  Digestive System Neoplasms (7)  ·  Gastrointestinal Diseases (7)  ·  Gastrointestinal Neoplasms (7)  ·  Neoplasms by Site (7)  ·  Stomach Diseases (7)  ·  Neoplasms (6)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Biliary Tract Diseases (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Bronchogenic (1)  ·  Colonic Diseases (1)  ·  Endocrine Gland Neoplasms (1)

Interventions

Oxaliplatin (2)  ·  Capecitabine (1)  ·  Paclitaxel (1)  ·  S 1 (combination) (1)  ·  Tegafur (1)  ·  camrelizumab (1)  ·  ferrous succinate (1)  ·  ferrous sulfate (1)  ·  pyrotinib (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  ASLAN Pharmaceuticals (1)  ·  Fudan University (1)  ·  Haihua Yuan (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)  ·  University Hospital Tuebingen (1)

Countries

China (2)  ·  United States (2)  ·  Germany (1)  ·  South Korea (1)

Top investigators

Andrew Blakely, M.D. (1)  ·  Jeremy L Davis, M.D. (1)  ·  Seock-Ah Im, Dr. (1)

Results publications

PMID 31183189, PMID 34012620